Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gibb

Showing results (281-290 of 368) with videos related to

Pageof 37
Sort By:
Health Technology Assessment (Winchester, England)|November 5, 2021
Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCTSam Barratt, Julia A Bielicki, David Dunn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 16, 2025
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIVAnne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, et al.
The Journal of Infectious Diseases|May 19, 2016
Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral TherapyAndrew J Prendergast, Alexander J Szubert, Chipo Berejena, et al.
AIDS (London, England)|April 12, 2016
Once vs twice-daily abacavir and lamivudine in African childrenVictor Musiime, Philip Kasirye, Bethany Naidoo-James, et al.
The New England Journal of Medicine|January 3, 2014
A randomized trial of prolonged co-trimoxazole in HIV-infected children in AfricaMutsawashe Bwakura-Dangarembizi, Lindsay Kendall, Sabrina Bakeera-Kitaka, et al.
Antiviral Therapy|April 11, 2014
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trialVictor Musiime, Adrian Cook, Joshua Kayiwa, et al.
Critical Care (London, England)|November 29, 2019
Mortality risk over time after early fluid resuscitation in African childrenElizabeth C George, Sarah Kiguli, Peter Olupot Olupot, et al.
Wellcome Open Research|September 2, 2024
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)Kathryn Maitland, Mainga Hamaluba, Nchafatso Obonyo, et al.
Vox Sanguinis|March 7, 2019
Haematological quality and age of donor blood issued for paediatric transfusion to four hospitals in sub-Saharan AfricaSophie Uyoga, Ayub Mpoya, Peter Olupot-Olupot, et al.
The Journal of Infectious Diseases|November 27, 2009
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus AbacavirNicaise Ndembi, Nicasie Ndembi, Ruth L Goodall, et al.
Pageof 37

Showing results (281-290 of 368) with videos related to

Sort By:
Pageof 37
Health Technology Assessment (Winchester, England)|November 5, 2021
Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCTSam Barratt, Julia A Bielicki, David Dunn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 16, 2025
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIVAnne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, et al.
The Journal of Infectious Diseases|May 19, 2016
Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral TherapyAndrew J Prendergast, Alexander J Szubert, Chipo Berejena, et al.
AIDS (London, England)|April 12, 2016
Once vs twice-daily abacavir and lamivudine in African childrenVictor Musiime, Philip Kasirye, Bethany Naidoo-James, et al.
The New England Journal of Medicine|January 3, 2014
A randomized trial of prolonged co-trimoxazole in HIV-infected children in AfricaMutsawashe Bwakura-Dangarembizi, Lindsay Kendall, Sabrina Bakeera-Kitaka, et al.
Antiviral Therapy|April 11, 2014
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trialVictor Musiime, Adrian Cook, Joshua Kayiwa, et al.
Critical Care (London, England)|November 29, 2019
Mortality risk over time after early fluid resuscitation in African childrenElizabeth C George, Sarah Kiguli, Peter Olupot Olupot, et al.
Wellcome Open Research|September 2, 2024
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)Kathryn Maitland, Mainga Hamaluba, Nchafatso Obonyo, et al.
Vox Sanguinis|March 7, 2019
Haematological quality and age of donor blood issued for paediatric transfusion to four hospitals in sub-Saharan AfricaSophie Uyoga, Ayub Mpoya, Peter Olupot-Olupot, et al.
The Journal of Infectious Diseases|November 27, 2009
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus AbacavirNicaise Ndembi, Nicasie Ndembi, Ruth L Goodall, et al.
Pageof 37